De la Fuente JM - Search Results

1

Interconnection between biological abnormalities in borderline personality disorder: use of the Bayesian networks model.

De la Fuente JM, Bengoetxea E, Navarro F, Bobes J, Alarcón RD. De la Fuente JM, et al. Psychiatry Res. 2011 Apr 30;186(2-3):315-9. doi: 10.1016/j.psychres.2010.08.027. Epub 2010 Sep 21. Psychiatry Res. 2011. PMID: 20858567

2

Effects of carbamazepine on dexamethasone suppression and sleep electroencephalography in borderline personality disorder.

De la Fuente JM, Bobes J, Vizuete C, Mendlewicz J. De la Fuente JM, et al. Neuropsychobiology. 2002;45(3):113-9. doi: 10.1159/000054948. Neuropsychobiology. 2002. PMID: 11979058 Clinical Trial.

3

Biological nature of depressive symptoms in borderline personality disorder: endocrine comparison to recurrent brief and major depression.

De la Fuente JM, Bobes J, Vizuete C, Mendlewicz J. De la Fuente JM, et al. J Psychiatr Res. 2002 May-Jun;36(3):137-45. doi: 10.1016/s0022-3956(01)00056-5. J Psychiatr Res. 2002. PMID: 11886691

4

Is the biological nature of depressive symptoms in borderline patients without concomitant Axis I pathology idiosyncratic? Sleep EEG comparison with recurrent brief, major depression and control subjects.

De la Fuente JM, Bobes J, Morlán I, Bascarán MT, Vizuete C, Linkowski P, Mendlewicz J. De la Fuente JM, et al. Psychiatry Res. 2004 Nov 30;129(1):65-73. doi: 10.1016/j.psychres.2004.05.025. Psychiatry Res. 2004. PMID: 15572186

5

Neurologic soft signs in borderline personality disorder.

De la Fuente JM, Bobes J, Vizuete C, Bascaran MT, Morlán I, Mendlewicz J. De la Fuente JM, et al. J Clin Psychiatry. 2006 Apr;67(4):541-6. doi: 10.4088/jcp.v67n0404. J Clin Psychiatry. 2006. PMID: 16669718

6

Sleep-EEG in borderline patients without concomitant major depression: a comparison with major depressives and normal control subjects.

De la Fuente JM, Bobes J, Vizuete C, Mendlewicz J. De la Fuente JM, et al. Psychiatry Res. 2001 Dec 15;105(1-2):87-95. doi: 10.1016/s0165-1781(01)00330-4. Psychiatry Res. 2001. PMID: 11740978

7

Issues for DSM-V: I) including biological variables to objectively comfort the clinical diagnosis of borderline personality disorder and II) proposing a new subcategory to be included in the criteria sets for further study.

De la Fuente JM, Bobes J. De la Fuente JM, et al. Int J Soc Psychiatry. 2009 May;55(3):195-7. doi: 10.1177/0020764008093577. Int J Soc Psychiatry. 2009. PMID: 19383662 No abstract available.

8

Brain glucose metabolism in borderline personality disorder.

De La Fuente JM, Goldman S, Stanus E, Vizuete C, Morlán I, Bobes J, Mendlewicz J. De La Fuente JM, et al. J Psychiatr Res. 1997 Sep-Oct;31(5):531-41. doi: 10.1016/s0022-3956(97)00001-0. J Psychiatr Res. 1997. PMID: 9368195

9

Electroencephalographic abnormalities in borderline personality disorder.

De la Fuente JM, Tugendhaft P, Mavroudakis N. De la Fuente JM, et al. Psychiatry Res. 1998 Feb 9;77(2):131-8. doi: 10.1016/s0165-1781(97)00149-2. Psychiatry Res. 1998. PMID: 9541149 Clinical Trial.

10

Temporal glucose metabolism in borderline personality disorder.

de la Fuente JM, Lotstra F, Goldman S, Biver F, Luxen A, Bidaut L, Stanus E, Mendlewicz J. de la Fuente JM, et al. Psychiatry Res. 1994 Dec;55(4):237-45. doi: 10.1016/0925-4927(94)90017-5. Psychiatry Res. 1994. PMID: 7701037

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

219 results

Search Page

Filters